Related Experiment Video
Updated: Aug 27, 2025

08:30
Microinjectrode System for Combined Drug Infusion and Electrophysiology
Published on: November 13, 2019
6.9K
A microexplosive shockwave-based drug delivery microsystem for treating hard-to-reach areas in the human body
Yi Sun1,2, Wenzhong Lou1,2, Hengzhen Feng1,2
1Science and Technology on Electromechanical Dynamic Control Laboratory, School of Mechatronical Engineering, Beijing Institute of technology, Beijing, China.
Microsystems & Nanoengineering
|September 27, 2022
Summary
This study developed novel microsystems for targeted drug delivery to curved internal organ lesions. These microshockwave devices improve drug efficacy and minimize side effects in difficult-to-reach areas.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Medical Device Development
Background:
- Internal organ lesions in the esophagus, gastrointestinal tract, and respiratory tract often occur in curved or zigzag areas.
- Existing therapeutic modalities have limited ability for localized drug delivery to these complex anatomical regions.
- Effective treatment requires methods to deliver drugs precisely to these challenging lesion sites.
Purpose of the Study:
- To develop and evaluate innovative microsystems for targeted drug delivery using microshockwave technology.
- To create a device capable of depositing drugs onto mucous membranes in curved or zigzag endoluminal areas.
- To assess the biosafety and drug delivery capacity of these novel microsystems.
Main Methods:
- Development of microsystems with a warhead-like shell containing drug powder and a flexible rod.
- Numerical simulation to analyze the explosive impact characteristics during drug delivery.
- In vivo experiments involving drug delivery in pig intestines to evaluate biosafety and efficacy.
Main Results:
- The developed microsystems demonstrated the capacity to deposit drugs on mucous membranes in curved or zigzag anatomical locations.
- Numerical simulations provided insights into the explosive impact dynamics of the drug delivery device.
- In vivo testing confirmed the biosafety and drug delivery capabilities of the system in a relevant biological model.
Conclusions:
- The novel microsystems offer a promising approach for localized drug delivery to challenging endoluminal lesions.
- This technology has the potential to maximize on-target drug effects and minimize systemic side effects for various endoluminal diseases.
- Further application in curved or zigzag regions of the human body is anticipated for improved therapeutic outcomes.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
376
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
376
Drug Delivery: Miscellaneous Routes
444
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
444

